App Central Berman's Call BTV - Business Television Business Day Car Business Commodities C-Suite Survey ETF Update GetConnected Headline Market Call
Market Call Tonight Market Sense MoneyTalk The Business News The Close The Learning Curve The Pitch The Street Undercover Boss Weekly with Andrew McCreath
View full programming schedule
Future of Keystone XL Agrium Proxy Battle Federal Budget 2013 Your Money Month PDAC 2013 BNN Book Club Passion Capitalist Financial Glossary Bell Let's Talk Talking Tax C-Suite Survey SNC-Lavalin Annual Meeting

Are you looking for a stock?

Try one of these

View more results

Valeant CEO talks about Afexa bid

BNN.ca staff
4:06 PM, E.T. | August 30, 2011
Canadian
Tags: Afexa Life Sciences , Valeant Pharmaceuticals
A
A
 
Follow this
Valeant Pharmaceuticals is looking to add another company to its lengthy list of acquisitions after it announced on Tuesday a friendly $76-million bid for Afexa Life Sciences. Chairman and CEO Mike Pearson talks to BNN about Valeant's offer.
DISLIKE
 
COMMENTS
 
0
Latest News
Popular News
More Stories
CTV.ca CTV Two CTV News Channel BNN - Business News Network CP24